Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

NCT02367547 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

117

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms, Basal Cell
Carcinoma, Basal Cell
Photochemotherapy
Photosensitizing Agents

Interventions

DRUG: Hexylaminolevulinate cream
DRUG: Aminolevulinic Acid Nano Emulsion
DRUG: Methylaminolevulinate cream

Sponsor

Joint Authority for Päijät-Häme Social and Health Care

Collaborators

[object Object]
[object Object]